Literature DB >> 3819695

Mechanism of protection during the early phase of a generalized viral infection. II. Contribution of polymorphonuclear leukocytes to protection against intravenous infection with influenza virus.

S Tsuru, H Fujisawa, M Taniguchi, Y Zinnaka, K Nomoto.   

Abstract

The contribution of phagocytes to the early protection of mice inoculated intravenously with influenza virus was investigated in phagocyte-depleted mice. Following the inoculation of a sublethal dose of influenza virus, virus titres in the liver and lung of both untreated and carrageenan-treated mice were reduced rapidly by day 1 and decreased slowly to reach an undetectable level by day 7. The titres in gamma-irradiated mice decreased transiently by day 1 and increased progressively thereafter to kill all of the hosts by day 8. The clearance of virus from blood at the early stage of infection was retarded by gamma-irradiation but not by carrageenan treatment. In addition, increase in virus titres in the liver and lung in the early stage of the infection was prevented by adoptive transfer with syngeneic polymorphonuclear leukocytes into gamma-irradiated mice. No significant rise of neutralizing antibody was detectable by day 3 after the inoculation, in any of the three groups of mice. These observations imply that gamma-sensitive and carrageenan-resistant polymorphonuclear leukocytes play a protective role at the early stage in the infection, whereas fixed macrophages or natural killer cells, both of which are carrageenan-sensitive and gamma-resistant, scarcely participate in the early phase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3819695     DOI: 10.1099/0022-1317-68-2-419

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Tumour necrosis factor triggers granulocytes to internalize complement-coated virus particles.

Authors:  J A van Strijp; M E van der Tol; L A Miltenburg; K P van Kessel; J Verhoef
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

2.  rVSV(M Delta 51)-M3 is an effective and safe oncolytic virus for cancer therapy.

Authors:  Lan Wu; Tian-gui Huang; Marcia Meseck; Jennifer Altomonte; Oliver Ebert; Katsunori Shinozaki; Adolfo García-Sastre; John Fallon; John Mandeli; Savio L C Woo
Journal:  Hum Gene Ther       Date:  2008-06       Impact factor: 5.695

3.  Complement-mediated phagocytosis of herpes simplex virus by granulocytes. Binding or ingestion.

Authors:  J A Van Strijp; K P Van Kessel; M E van der Tol; J Verhoef
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

4.  Immunological memory in latent Japanese encephalitis virus infection.

Authors:  R Kulshreshtha; A Mathur; U C Chaturvedi
Journal:  Br J Exp Pathol       Date:  1988-08

5.  Immunopathological study of spleen during Japanese encephalitis virus infection in mice.

Authors:  A Mathur; M Bharadwaj; R Kulshreshtha; S Rawat; A Jain; U C Chaturvedi
Journal:  Br J Exp Pathol       Date:  1988-06

6.  Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice.

Authors:  Terrence M Tumpey; Adolfo García-Sastre; Jeffery K Taubenberger; Peter Palese; David E Swayne; Mary J Pantin-Jackwood; Stacey Schultz-Cherry; Alicia Solórzano; Nico Van Rooijen; Jacqueline M Katz; Christopher F Basler
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

7.  Phagocytosis of herpes simplex virus by human granulocytes and monocytes.

Authors:  J A Van Strijp; K P Van Kessel; M E van der Tol; A C Fluit; H Snippe; J Verhoef
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

8.  Antioxidant treatment ameliorates respiratory syncytial virus-induced disease and lung inflammation.

Authors:  Shawn Monique Castro; Antonieta Guerrero-Plata; Giovanni Suarez-Real; Patrick A Adegboyega; Giuseppe N Colasurdo; Amir M Khan; Roberto P Garofalo; Antonella Casola
Journal:  Am J Respir Crit Care Med       Date:  2006-09-28       Impact factor: 21.405

9.  Innate immunity to influenza virus: implications for future therapy.

Authors:  Mitchell R White; Mona Doss; Patrick Boland; Tesfaldet Tecle; Kevan L Hartshorn
Journal:  Expert Rev Clin Immunol       Date:  2008-07-01       Impact factor: 4.473

10.  Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea.

Authors:  T M Tumpey; S H Chen; J E Oakes; R N Lausch
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.